Governance of interactions with pharmaceutical factories addressed
Published: 04:09 PM,Sep 12,2024 | EDITED : 08:09 PM,Sep 12,2024
The committee reviewed modern medications, emphasising their quality and prioritizing Omani national factories and institutions. - ONA
MUSCAT: The Healthcare Management and Organisation Committee on Thursday held its second meeting under under the chairmanship of Dr Hilal bin Ali al Sabti, Minister of Health.
The committee addressed the governance of interactions with pharmaceutical factories and health product suppliers with the purpose of regulating the distribution of unauthorised medications within the Sultanate of Oman to ensure the protection of public health.
Additionally, the committee reviewed modern medications, emphasising their quality and prioritising Omani national factories and institutions.
The Director General of Private Health Establishments gave during the meeting a presentation on the regulations for permitting government health professionals to work in private health institutions, according to updated guidelines.
The Director of the Treatment Abroad Department presented an overview of the current challenges and discussed possible solutions related to treatment abroad.
Furthermore, the Healthcare Management and Organisation Committee recommended the governance of certain practices and the issuance of ministerial decisions to regulate the handling of blood samples sent abroad, ensuring that these samples are sent to medical laboratories accredited by the Sultanate of Oman.
The committee is responsible for developing strategies, programmes, and national policies for integrating civil and military health units in the Sultanate of Oman, organising and coordinating the smooth and seamless transfer of human resources between these units. — ONA
The committee addressed the governance of interactions with pharmaceutical factories and health product suppliers with the purpose of regulating the distribution of unauthorised medications within the Sultanate of Oman to ensure the protection of public health.
Additionally, the committee reviewed modern medications, emphasising their quality and prioritising Omani national factories and institutions.
The Director General of Private Health Establishments gave during the meeting a presentation on the regulations for permitting government health professionals to work in private health institutions, according to updated guidelines.
The Director of the Treatment Abroad Department presented an overview of the current challenges and discussed possible solutions related to treatment abroad.
Furthermore, the Healthcare Management and Organisation Committee recommended the governance of certain practices and the issuance of ministerial decisions to regulate the handling of blood samples sent abroad, ensuring that these samples are sent to medical laboratories accredited by the Sultanate of Oman.
The committee is responsible for developing strategies, programmes, and national policies for integrating civil and military health units in the Sultanate of Oman, organising and coordinating the smooth and seamless transfer of human resources between these units. — ONA